Passa al contenuto
Merck

Vai a

C8571

Cathepsin B from human liver

buffered aqueous solution, ≥200 units/mg protein (One unit is defined as the amount of enzyme that hydrolyzes 1 μmol of Z-Arg-Arg-beta-naphthylamide per minute at 40 °C, using 100 mM Na/K phosphate, pH 6.0, with 1.33 mM EDTA and 2 mM DTT as the activation buffer.)

Sinonimo/i:

Cathepsin B1

Autenticati per visualizzare i prezzi organizzativi e contrattuali.

Scegli un formato

Cambia visualizzazione
Voi/SKUDisponibilitàPrezzo
25 μg
Per informazioni sulla disponibilità, contatta il Servizio Clienti.
426,00 €

Informazioni su questo articolo

Numero CAS:
UNSPSC Code:
12352200
NACRES:
NA.32
Numero CE:
MDL number:
eCl@ss:
32160703
Specific activity:
≥200 units/mg protein (One unit is defined as the amount of enzyme that hydrolyzes 1 μmol of Z-Arg-Arg-beta-naphthylamide per minute at 40 °C, using 100 mM Na/K phosphate, pH 6.0, with 1.33 mM EDTA and 2 mM DTT as the activation buffer.)
Biological source:
human liver

426,00 €


Per informazioni sulla disponibilità, contatta il Servizio Clienti.

​
Richiedi un ordine personalizzato
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutarti


biological source

human liver

Quality Segment

form

buffered aqueous solution

specific activity

≥200 units/mg protein (One unit is defined as the amount of enzyme that hydrolyzes 1 μmol of Z-Arg-Arg-beta-naphthylamide per minute at 40 °C, using 100 mM Na/K phosphate, pH 6.0, with 1.33 mM EDTA and 2 mM DTT as the activation buffer.)

UniProt accession no.

shipped in

dry ice

storage temp.

−70°C

Gene Information

human ... CTSB(1508)

General description

Cathepsin B gene is mapped to human chromosome 8p23.1. It is a lysosomal cysteine with 252 amino acids distributed in two chains and is homologous to rat liver sequence. It has disc shaped structure with two domains namely the left-hand ′L′ domain at the amino terminal and right hand ′R′ domain at the carboxyl-terminal.

Application

Cathepsin B from human liver has been used:
  • as a positive control in the screening Cathepsin B inhibitor assay
  • in wall extension (expansin activity) assay
  • in microinjection human foreskin fibroblasts to test its effect on apoptosis induction

Biochem/physiol Actions

Cathepsin B from human liver is highly expressed in the esophageal adenocarcinoma (EAC). It reduces hepatic inflammation and fibrogenesis and may serve as a potential candidate for treating liver diseases.
Cathepsin B has been found to cleave procaspase 1 and procaspase 11 and to induce apoptosis in digitonin-permeabilized cells. Translocation of cathepsin B from the cytoplasm to the nucleus contributes to bile salt induced apoptosis of rat hepatocytes. Levels of cathepsin B in PC12 cells significantly decrease 12 to 24 hours after apoptosis is induced.
Found to cleave procaspase 1 and procaspase 11 and to induce apoptosis in digitonin-permeabilized cells.

Packaging

Package size based on protein content

Physical form

Solution in 50 mM sodium acetate, pH 5.0, with 1 mM EDTA.

Other Notes

One unit will liberate 1 nanomole of 7-amino-4-methylcoumarin from Z-Arg-Arg 7-amido-4-methylcoumarin per min at pH 6.0 at 40 °C.

Confronta articoli simili

Visualizza il confronto per intero

Mostra le differenze

1 of 1

Questo articolo
C0150219362SRP0289
description

buffered aqueous solution, ≥200 units/mg protein (One unit is defined as the amount of enzyme that hydrolyzes 1 μmol of Z-Arg-Arg-beta-naphthylamide per minute at 40 °C, using 100 mM Na/K phosphate, pH 6.0, with 1.33 mM EDTA and 2 mM DTT as the activation buffer.)

description

lyophilized powder, ≥5 units/mg protein

description

Cathepsin B, Human Liver, CAS 9047-22-7, is a purified native cathepsin B from human liver, purified by affinity chromatography. Upregulated in many types of tumors.

description

recombinant, expressed in FreeStyle™ 293-F cells, ≥90% (SDS-PAGE)

specific activity

≥200 units/mg protein (One unit is defined as the amount of enzyme that hydrolyzes 1 μmol of Z-Arg-Arg-beta-naphthylamide per minute at 40 °C, using 100 mM Na/K phosphate, pH 6.0, with 1.33 mM EDTA and 2 mM DTT as the activation buffer.)

specific activity

≥5 units/mg protein

specific activity

≥10 units/mg protein

specific activity

≥2228 pmol/min-μg

Gene Information

human ... CTSB(1508)

Gene Information

human ... CTSB(1508)

Gene Information

human ... CTSB(1508)

Gene Information

human ... CTSB(1508)

biological source

human liver

biological source

-

biological source

human liver

biological source

human

form

buffered aqueous solution

form

lyophilized powder

form

liquid

form

aqueous solution

UniProt accession no.

P07858

UniProt accession no.

P07858

UniProt accession no.

-

UniProt accession no.

-

storage temp.

−70°C

storage temp.

−20°C

storage temp.

−70°C

storage temp.

−70°C


Classe di stoccaggio

10 - Combustible liquids

WGK

WGK 3

Punto di infiammabilità (°F)

Not applicable

Punto di infiammabilità (°C)

Not applicable



Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documenti section.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti




Domande

  1. how to reconstitute the cathepsin B? If it is written >1500units/mg, and C8571-25UG, how come it is in aqeous solution?

    1 risposta
    1. The product is a buffered aqueous solution, not a lyophilized powder, so it does not require reconstitution. The solution contains Cathepsin B at a specific protein concentration and activity, both of which are lot-dependent and provided on the CoA.

      Utile?

Recensioni

Nessuna valutazione

Filtri attivi